Literature DB >> 25844958

Presentation and progression of childhood-onset inflammatory bowel disease in Northern Stockholm County.

Petter Malmborg1, Lena Grahnquist, Maja Ideström, Johan Lindholm, Ragnar Befrits, Jan Björk, Scott Montgomery, Hans Hildebrand.   

Abstract

BACKGROUND: Some studies have suggested that childhood-onset inflammatory bowel disease (IBD) is characterized by extensive intestinal involvement and rapid progression to complications. Here, we report the presentation and progression of patients diagnosed with IBD during childhood in a population-based cohort from northern Stockholm County.
METHODS: Medical records for all 280 patients diagnosed in the period 1990-2007 with childhood-onset IBD in northern Stockholm County were followed until 2011 (median follow-up time, 8.8 yr). Disease phenotypes were classified according to the Paris pediatric IBD classification.
RESULTS: Among the 74 patients with ulcerative colitis, 72% presented with pancolitis. Among the 200 patients with Crohn's disease (CD), 75% presented with colitis. Complicated disease behavior was observed in 18% of patients with CD by end of follow-up. Extension of the disease territory was observed in 22% of patients with ulcerative colitis and 15% of patients with CD. The cumulative risk of intra-abdominal surgery after 10 years was 8% (95% confidence interval, 4%-20%) for ulcerative colitis and 22% (95% confidence interval, 15%-28%) for patients with CD. Nonmucosal healing at 1 year was associated with a complicated disease course in patients with CD (hazard ratio = 14.56; 95% confidence interval, 1.79-118.68; P = 0.01).
CONCLUSIONS: Patients with childhood-onset IBD were characterized by extensive colitis that was relatively stable over time and associated with a relatively low risk of complications and abdominal surgery. Our findings confirm the more extensive disease location in pediatric IBD but did not identify the proposed dynamic and aggressive nature of the childhood-onset phenotype. The association of nonmucosal healing with a complicated disease course suggests that endoscopy should guide treatment intensity in childhood-onset CD.

Entities:  

Mesh:

Year:  2015        PMID: 25844958     DOI: 10.1097/MIB.0000000000000356

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

1.  Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.

Authors:  J Dhaliwal; T D Walters; D R Mack; H Q Huynh; K Jacobson; A R Otley; J Debruyn; W El-Matary; C Deslandres; M E Sherlock; J N Critch; K Bax; E Seidman; P Jantchou; A Ricciuto; M Rashid; A M Muise; E Wine; M Carroll; S Lawrence; J Van Limbergen; E I Benchimol; P Church; A M Griffiths
Journal:  J Crohns Colitis       Date:  2020-05-21       Impact factor: 9.071

2.  A baseline assessment of enhanced recovery protocol implementation at pediatric surgery practices performing inflammatory bowel disease operations.

Authors:  Jonathan Vacek; Teaniese Davis; Benjamin T Many; Sharron Close; Sarah Blake; Yue-Yung Hu; Jane L Holl; Julie Johnson; Jennifer Strople; Mehul V Raval
Journal:  J Pediatr Surg       Date:  2020-06-27       Impact factor: 2.545

3.  Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy.

Authors:  Jonathan R Dillman; Soudabeh Fazeli Dehkordy; Ethan A Smith; Michael A DiPietro; Ramon Sanchez; Vera DeMatos-Maillard; Jeremy Adler; Bin Zhang; Andrew T Trout
Journal:  Pediatr Radiol       Date:  2017-04-18

4.  Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis.

Authors:  Fei Sjöberg; Cecilia Barkman; Intawat Nookaew; Sofia Östman; Ingegerd Adlerberth; Robert Saalman; Agnes E Wold
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

5.  Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014.

Authors:  O Olén; J Askling; M C Sachs; P Frumento; M Neovius; K E Smedby; A Ekbom; P Malmborg; J F Ludvigsson
Journal:  BMJ       Date:  2017-09-20

6.  Serological cytokine signature in paediatric patients with inflammatory bowel disease impacts diagnosis.

Authors:  Maiko Tatsuki; Reiko Hatori; Tomoko Nakazawa; Takashi Ishige; Tomoko Hara; Seiichi Kagimoto; Takeshi Tomomasa; Hirokazu Arakawa; Takumi Takizawa
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

7.  Earnings during adulthood in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study.

Authors:  Petter Malmborg; Åsa H Everhov; Jonas Söderling; Jonas F Ludvigsson; Gustaf Bruze; Ola Olén
Journal:  Aliment Pharmacol Ther       Date:  2022-08-02       Impact factor: 9.524

Review 8.  Endoscopic and Histologic Predictors of Outcomes in Pediatric Ulcerative Colitis-Caveat Emptor.

Authors:  Lorraine Stallard; Séamus Hussey
Journal:  Front Pediatr       Date:  2021-06-23       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.